frequently-asked-questions

BHG CEO Announcement | Opioid Addiction Treatment Services

Behavioral Health Group Announces Transition of CEO Andrew Love to Advisory Role; Board Appoints Chairman, Mike Cannizzaro, as Chairman and CEO

DALLAS, TX, July 25, 2012 /PRNewswire/ — The Board of Directors of Behavioral Health Group (“BHG” or “the Company”) today announced that Andrew Love has stepped down as Chief Executive Officer and Director and has transitioned to a consulting role with the Company as he pursues a new opportunity. He is succeeded by Michael N. Cannizzaro, BHG’s Chairman.

 

Andy said of his transition: “It was an honor to build and lead BHG from inception to its sale a year ago to the Frontenac Company. I am delighted to continue working together with the leadership team of professionals at BHG and Frontenac, and I am grateful for the support I’ve received from the Board of Directors and our team members over the last six years as we have built BHG into a leader in the field of opioid addiction treatment.”

 

Mr. Love added, “BHG’s growth will undoubtedly accelerate under the outstanding and experienced leadership of Mike Cannizzaro, with whom I have enjoyed working over the last year. I look forward to my continued support of BHG as a co-founder, advisor, and shareholder.”

 

BHG’s Chairman and CEO, Mike Cannizzaro, said: “The Board expresses its gratitude to Andy for his dedicated service to BHG since co-founding the company in 2006, and we thank him for the vision and leadership he brought to the company. We are delighted that we will be able to draw on Andy’s talents and experience through his participation as an advisor to the Company. We wish him every success in his future endeavors.”

 

Mike Cannizzaro, Chairman and CEO, has 36 years of leadership experience in healthcare companies, including Baxter Healthcare, Caremark International, Beltone Electronics, National Nephrology, and Sunrise Medical, to name a few. He was also an operating partner of JW Childs Associates, a leading private equity firm based in Boston.

 

About Behavioral Health Group

 

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. BHG utilizes pharmacotherapy (maintenance and detoxification) and behavioral therapy (counseling) to treat both the bio-chemical and psycho-social aspects of addiction. In doing so, BHG offers its patients their best shot at successful recovery. With 23 outpatient treatment centers across the midwest/south/southeast, BHG provides a critical service to thousands of individuals and their communities across the country. BHG’s treatment centers are accredited by The Joint Commission.

 

For more information, call (214) 365-6100, email inquiries@bhgrecovery.com, or visit http://www.bhgrecovery.com.

 

Behavioral Health Group Contact: James F. Draudt

Frequently Asked Questions:

Q
A

Q: Why do we need an opioid treatment facility in this community?

Drug addiction ignores every socio-economic variable and finds its way into all communities. Treating addiction is far less costly than ignoring addiction. Demographic data on patients indicates that the vast majority of patients in treatment have long associations with the community as a person struggling with their disease. It is far better to provide and […]

MORE

Words From Our Patients:

The methadone maintenance program at BHG has helped me tremendously to stay off heroin, and my counselor is great. She is down to earth, and I feel that she knows me. Without this program, I would surely be dead sooner or later, and it is helping me with my relationship with my fiancé.

MORE